ReviewDiabetes, obesity & metabolism2021

Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.

Chin Meng Khoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.